Beijing Bohui Innovation Technology Co Ltd (300318) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Beijing Bohui Innovation Technology Co Ltd (300318) has a cash flow conversion efficiency ratio of -0.027x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-62.46 Million ≈ $-9.14 Million USD) by net assets (CN¥2.29 Billion ≈ $334.87 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Beijing Bohui Innovation Technology Co Ltd - Cash Flow Conversion Efficiency Trend (2006–2024)
This chart illustrates how Beijing Bohui Innovation Technology Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Beijing Bohui Innovation Technology Co L total liabilities for a breakdown of total debt and financial obligations.
Beijing Bohui Innovation Technology Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Beijing Bohui Innovation Technology Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Zhejiang Kanglongda Special
SHG:603665
|
0.024x |
|
Shanghai Canature Environmental
SHE:300272
|
0.029x |
|
Yongji Printing Co Ltd
SHG:603058
|
0.005x |
|
Newcapec Electronics Co Ltd
SHE:300248
|
0.022x |
|
Pet Acquisition LLC
NASDAQ:WOOF
|
0.078x |
|
Grupo Supervielle S.A. B
BA:SUPV
|
0.176x |
|
Bravura Solutions Ltd
AU:BVS
|
0.471x |
|
QuinStreet Inc
NASDAQ:QNST
|
0.073x |
Annual Cash Flow Conversion Efficiency for Beijing Bohui Innovation Technology Co Ltd (2006–2024)
The table below shows the annual cash flow conversion efficiency of Beijing Bohui Innovation Technology Co Ltd from 2006 to 2024. For the full company profile with market capitalisation and key ratios, see 300318 market cap overview.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥2.35 Billion ≈ $343.75 Million |
CN¥-38.69 Million ≈ $-5.66 Million |
-0.016x | -128.13% |
| 2023-12-31 | CN¥2.34 Billion ≈ $342.50 Million |
CN¥137.02 Million ≈ $20.05 Million |
0.059x | +234.10% |
| 2022-12-31 | CN¥2.32 Billion ≈ $340.06 Million |
CN¥40.72 Million ≈ $5.96 Million |
0.018x | +1740.95% |
| 2021-12-31 | CN¥932.75 Million ≈ $136.49 Million |
CN¥887.78K ≈ $129.91K |
0.001x | -98.41% |
| 2020-12-31 | CN¥1.44 Billion ≈ $210.56 Million |
CN¥86.14 Million ≈ $12.60 Million |
0.060x | +274.83% |
| 2019-12-31 | CN¥1.05 Billion ≈ $153.96 Million |
CN¥-36.03 Million ≈ $-5.27 Million |
-0.034x | +49.38% |
| 2018-12-31 | CN¥1.24 Billion ≈ $182.03 Million |
CN¥-84.15 Million ≈ $-12.31 Million |
-0.068x | -14.67% |
| 2017-12-31 | CN¥1.61 Billion ≈ $236.13 Million |
CN¥-95.19 Million ≈ $-13.93 Million |
-0.059x | -215.34% |
| 2016-12-31 | CN¥1.52 Billion ≈ $223.07 Million |
CN¥77.97 Million ≈ $11.41 Million |
0.051x | -26.21% |
| 2015-12-31 | CN¥1.28 Billion ≈ $187.79 Million |
CN¥88.95 Million ≈ $13.02 Million |
0.069x | +62.20% |
| 2014-12-31 | CN¥726.57 Million ≈ $106.32 Million |
CN¥31.05 Million ≈ $4.54 Million |
0.043x | -45.49% |
| 2013-12-31 | CN¥702.55 Million ≈ $102.81 Million |
CN¥55.08 Million ≈ $8.06 Million |
0.078x | -15.69% |
| 2012-12-31 | CN¥658.98 Million ≈ $96.43 Million |
CN¥61.28 Million ≈ $8.97 Million |
0.093x | -50.52% |
| 2011-12-31 | CN¥249.52 Million ≈ $36.51 Million |
CN¥46.89 Million ≈ $6.86 Million |
0.188x | +20.11% |
| 2010-12-31 | CN¥206.00 Million ≈ $30.14 Million |
CN¥32.23 Million ≈ $4.72 Million |
0.156x | +16.48% |
| 2009-12-31 | CN¥169.62 Million ≈ $24.82 Million |
CN¥22.79 Million ≈ $3.33 Million |
0.134x | +13.86% |
| 2008-12-31 | CN¥135.96 Million ≈ $19.89 Million |
CN¥16.04 Million ≈ $2.35 Million |
0.118x | -49.74% |
| 2007-12-31 | CN¥99.25 Million ≈ $14.52 Million |
CN¥23.30 Million ≈ $3.41 Million |
0.235x | +92.14% |
| 2006-12-31 | CN¥76.95 Million ≈ $11.26 Million |
CN¥9.40 Million ≈ $1.38 Million |
0.122x | -- |
About Beijing Bohui Innovation Technology Co Ltd
Beijing Bohui Innovation Biotechnology Group Co., Ltd. engages in the research and development, production, sale, and after-sale service of diagnostic products in China. The company offers human immunoglobulin for rabies, tetanus, hepatitis B, and intravenous injections; albumin; human prothrombin complex; and vaccine for rabies. It also provides molecular platform, such as Automatic Real-time Fl… Read more